Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metagenomic sequencing as a diagnostic tool for urine culture negative febrile urinary tract infection.

The Journal of infection·2026
Same author

Intubation Rather Than Cardiac Arrest as a Risk-Modifier of Mortality in Infarction-Related Cardiogenic Shock.

Journal of cardiac failure·2026
Same author

Understanding patients with mechanical circulatory support for cardiogenic shock: The role of preceding cardiac arrest.

Resuscitation·2026
Same author

Human carriage of ESBL/pAmpC-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in relation to the consumption of raw or undercooked vegetables, fruits, and fresh herbs.

Microbiology spectrum·2024
Same author

Coronary CT angiography for suspected acute coronary syndrome: sex-associated differences.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2021
Same author

Experience of establishing severe acute respiratory surveillance in the Netherlands: Evaluation and challenges.

Public health in practice (Oxford, England)·2021

Related Experiment Video

Updated: Jul 7, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

[New drugs; daptomycin].

H van Bronswijk1, E A Dubois, J T van Dissel

  • 1Leids Universitair Medisch Centrum, Albinusdreef 2, 2333 ZA Leiden.

Nederlands Tijdschrift Voor Geneeskunde
|February 1, 2008
PubMed
Summary
This summary is machine-generated.

Daptomycin is a novel cyclic lipopeptide antibiotic effective against Gram-positive bacteria by disrupting their cell membranes. It is approved for skin infections but has limited data for Staphylococcus aureus bloodstream infections.

More Related Videos

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Related Experiment Videos

Last Updated: Jul 7, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Area of Science:

  • Microbiology
  • Pharmacology

Context:

  • Daptomycin represents a new class of cyclic lipopeptide antibiotics.
  • It exhibits bactericidal activity against Gram-positive bacteria.

Purpose:

  • To summarize the mechanism of action, clinical applications, and adverse effects of daptomycin.
  • To highlight its role in treating Gram-positive infections, including skin and soft tissue infections.

Summary:

  • Daptomycin functions by creating pores in bacterial membranes, leading to potassium leakage, depolarization, and cell death.
  • It is indicated for complicated skin and soft tissue infections caused by Gram-positive pathogens.
  • Limited clinical experience exists for treating Staphylococcus aureus bacteremia.

Impact:

  • Provides a concise overview of daptomycin's therapeutic profile.
  • Informs clinicians about its mechanism, efficacy, and safety considerations.
  • Identifies areas for further research, such as its use in bloodstream infections.